Exp. Dr. Elvina Almuradova

Departments Medical Oncology
Locations Tınaztepe Galen Bayraklı Hospital

Education

School: Azerbaijan 229@th school . Graduating with Honora

University: Azerbaijan Medical University 2004-2010.

Internship: Hacettepe Medical University 2010-2011

Residency: Center For Training of Physicians 2011-2012

Turkey, Ege Üniversity Hospital İnternal Medicine Department İnternal Medicine Specialization 2013-2017. Graduating with Honora

Turkey, Ege Üniversity Hospital Medical Oncology Department Medical Oncology Fellowship 2018 2021

Clinical trials: Taking part as a Subinvestigator in trials below

ESO/ESCO FELLOW : until august 2021

 

 

 

Page content is being updated.

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

 
 

a study of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) as a first line intervention in a PD-L1 selected population with participants with

 
 

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy

 
 

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency (CAPItello-281)

 
 

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC)

 
 

EMERALD-2: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as

 
 

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants

 
 

Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or

 

 

Publications:

1.Book Page: Overview of the teratment of RCC Türkiye Klinikleri; 2019. p.73-80.Article Language: TR Publisher: Türkiye Klinikleri. ISBN: ISBN: 978-605-034-038-9  Oncologycal Approach And Treatment And Treatment Options For Metastatic Rcc

2.Article: Case Report: Multiple endocrine neoplasia type 2B (MEN 2B) October 2017 DOI: 10.19161/etd.394375

3.Systemic treatment of bone metastasys DOI: 10.14292/totbid.dergisi.2019.79

4. Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost? Journal of Gastrointestinal Cancer DOI: 10.1007/s12029-020-00573-y

5. The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience December 2020  Journal of chemotherapy (Florence, Italy) DOI:  10.1080/1120009X.2020.1861531

6. ‘’Breast Cancer İn Woman Aged 75 Years And Older’’ June 2021 European Journal of Geriatrics and Gerontology

7. Serous Papillary Ovarian Type Tumors of the Testis:Two Rare Cases EJMI. 2021; 5(3): 414-416 | DOI: 10.14744/ejmi.2021.64251

8. Private: Does pelvic RT have an effect on recurrence in patients with resectable stage 4 rectal cancer? A multicenter retrospective analysis of metastatic rectal cancer patients not receiving pelvic radiotherapy. JBUON 2021 (AHEAD OF PRİNT)

9. Letter to editor: There are Two Ways of Spreading Light: To Be the Candle or the Mirror That Reflects It. J Oncol Sci. 2021;7(2):39-41 DOI: 10.37047/jos.2021-83165

 

Certifications and Courses:

1.İnternal Medicine Conference. Turkey Antalia 2016

2. Post-graduation update course in Oncology . İstanbul Turkey. 2018

3. Postgraduate Update Courses / Central Nervous System Tumors and Sarcomas Course.İstanbul Turkey

4.National Cancer Conference 17.04.2019 Antalya .Turkey

5. 2.Oncology Perspective with Youth Congress. Antalya . 16.02.2019 Turkey

6.Rare Cancer Symposium 22.04.2019 Izmir Turkey

7. CEGOG İO TRAİNİNG VİENNA AUSTRİA 01-03.03.2019

8. Multidisciplinary Head and Neck Cancers Congress 07.03.2019 Antalya Turkey

9.Aegean Hematology Oncology Conference 15.03.2019

10. 2.Melanom Preceptorship 01-03.04.2019 İzmir.Turkey

11. Recent Developments in Colorectal Cancer, Breast Cancer, Non small cell lung cancer and Castration resistant Prostate Cancer  Antwerp University Hospital - Multidisciplinary Oncology Centre of Antwerp (MOCA). Date: 19-20 September 2019

12.Basic Oncology Course 05.10.2019 İzmir Turkey

13.HEDEF CANCER 06.03.2020

14. Aegean Hematology Oncology Conference 13.03.2020

15.Gastrointestinal System Cancers Course 16.05.2020

16.ASCO 2020. Uptade course 01-05.06.2020

17. 10TH ONLINE EURASIAN UROONCOLOGY CONGRESS - JUNE 27-28, 2020

18. VİRTUAL TURKİSH MEDİCAL ONCOLOGY CONFERENCE 12-15.11.2010

19.4. NATIONAL IMMUNOLOGY AND CANCER CONGRESS 04.11.2020

20. 4.MULTİDİSPLİNARY LUNG CANCER MANAGMENT COURSE ASCO

21. GYNECOLOGYC CANCERS COURSE 12.2020

22.ONCOLOGİC GOOD CLİNİCAL RESEARCH COURSE /TURKEY 11.2020

23.Clinical Research Education 11.2020

24. 5th ESO-ESMO-RCE Clinical update on RARE ADULT SOLID CANCERS 16.01.2020

25. 9th International Gastrointestinal Cancers /speaker

26. 10th International Gastrointestinal Cancers /speaker

27.4.Immunotherapy and oncology Conference /speaker

28. MedicReS 2020 GOOD ONCOLOGY RESEARCH CONFERENCE /Chaır

 

 

CME/ABİM/AMA PRA/ESO-MORA EDUCATİON

 

ESMO E-Learning activity: The Neoadjuvant Approach to Personalise Breast Cancer 25.01.2020

İ3 HEALTH Exploring Novel Treatment Strategies for Metastatic Colorectal Cancer on June 11, 2020

NCCN Pharmacy Updates: Emerging Strategies in the Treatment of Venous Thromboembolism completed on Dec 23, 2020

NCCN Guidelines® Insights - Ovarian Cancer, Version 1.2019 completed on Jul 7, 2020

NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 completed on Sep 1, 2020

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to IndividualizedPatient Care - Ovarian Cancercompleted on Jan 25, 2021

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to IndividualizedPatient Care - Central Nervous System Cancers completed on Dec 18, 2020

ESMO E-Learning activity: Management of Hormone-Sensitive Prostate Cancer

Shifting Focus to HCC: How are Immunotherapy Combination StrategiesShaping the Outlook for Unresectable HCC? November 26, 2020-Medscape

PARP Inhibitors in newly diagnosed advanceed ovarian cancer.08.2020 -Medscape

HER2-Positive Breast Cancer : Metastatic setting 12.2020

Evaluating new data in treatment resistant GIST may 30.2020 Medscape

Cdk4/6 inhibitors september 4.2020 Medscape

Advances in metastatic colorectal cancer  Jul 15, 2020 Medscape

Advanced Bladder Cancer: Using personalised frontline therapy 13.08.2020 Medscape

Adjuvant EGFR TKI Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Current and Future Perspectives november 26,2020- Medscape

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach toIndividualized Patient Care - Rectal Cancer completed on Sep 1, 2020-NCCN

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach toIndividualized Patient Care - Breast Cancer completed on Jul 7, 2020-NCCN

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach toIndividualized Patient Care - Breast Cancercompleted on Jul 7, 2020-NCCN

 

MEMBERSHİP:

1.TURKİSH MEDİCAL ONCOLOGY SOCİETY-2018

2.ESMO 2018

3.ASCO 2019

4.ESO/ESCO 2021

 

Oral Presentations:

1.Recent Developments in Colorectal Cancer, Breast Cancer, Non small cell lung cancer and Castration resistant Prostate Cancer UZA Antwerp, Belgium:Case report

2.Characterıstıcs And Outcomes Of Patıents Wıth Bone Metastatıc Colorectal Cancer. İgicc 2019

4.’’ Serous Papillary Ovarian Type Tumors of the Testis: Two Rare Cases’’ – eua 2020

 

 

 

 

Click for More